LAURA H. CYPHERS

This case series investigated the rate of prostate cancer diagnoses among transgender women treated in the Veterans Affairs health system.
Source: JAMA Online First

In this narrative medicine essay, a family physician takes a moment-by-moment, one-step-at-a-time approach to move from her couch to recovery from treatment for lymphoblastic leukemia to finally reaching the cross-country ski trails.
Source: JAMA Online First

This Viewpoint discusses specific areas of improvement in the National Institutes of Health’s funding of and research criteria for clinical trials to be inclusive, transparent, and broad reaching.
Source: JAMA Online First

This JAMA Insights Clinical Update discusses the newer treatment option of extracorporeal cardiopulmonary resuscitation, particularly for patients with cardiac arrest who are not responsive to initial treatment.
Source: JAMA Online First

This study uses data from a Drug Enforcement Administration list of Drug Addiction Treatment Act (DATA)-waivered clinicians to examine trends in DATA-waivered clinicians’ active participation in prescribing buprenorphine overall and by patient limits between January 2017 and May 2021.
Source: JAMA Online First

People who are aged 65 years or older and have gotten 1 dose of a bivalent COVID-19 vaccine can now receive another at least 4 months after their previous dose, according to a statement by the US Food and Drug Administration (FDA). People who are immunocompromised and have received a bivalent COVID-19 vaccine can also get another after a minimum of 2 months.
Source: JAMA Online First

Discectomies for sciatica, a condition often caused by a herniated disk, might be better than nonsurgical treatments or epidural steroid injections for reducing leg pain and disability in some patients, although the improvements declined over time to a negligible benefit after 12 months. The findings from the analysis of 24 randomized clinical trials were supported by very low- and low-certainty evidence.
Source: JAMA Online First

Tranexamic acid, which slows blood clot breakdown, was no more effective than placebo for reducing maternal death or the need for blood transfusion after scheduled or emergency cesarean delivery nor did it reduce the proportion of patients who lost more than 1 L of blood, according to a large randomized clinical trial that included 11 000 participants from 31 US hospitals. There was no difference in medication-related adverse events between groups.
Source: JAMA Online First

This Medical News feature discusses a recent study that found in-office blood pressure readings varied from visit to visit, supporting the need for more frequent monitoring at home.
Source: JAMA Online First

This Medical News article discusses chronic weight management with semaglutide, sold under the brand names Ozempic and Wegovy.
Source: JAMA Online First